Gesco H1 FY26 EBIT rises 52.9% to EUR 12.69 million; revenue increases 4.8% to EUR 248.69 million
Reuters2026/08/12 05:27- Gesco posted group earnings after minority interests of EUR 7.81 million, up 72.1%, with EPS rising 71.1% to EUR 0.75.
- EBIT climbed 52.9% to EUR 12.69 million as sales rose 4.8% to EUR 248.69 million; ROS widened 160 basis points to 5.1%.
- EBITDA increased 32.5% to EUR 21.82 million; the EBITDA margin improved to 8.8% from 6.9%.
- Incoming orders rose 13.2% to EUR 272.03 million, lifting the book-to-bill ratio to 1.09 from 1.01.
- Management reaffirmed its 2026 outlook for sales of EUR 515-530 million, targeting group earnings after minority interests of EUR 15-20 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas
A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.
Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260
10-Yr Benchmark Govt Yields - Germany vs Other Nations
Crypto prices
More
